Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats.

BACKGROUND/AIMS Complement activation is induced by ischaemia-reperfusion (I/R) and the complement factor C5a plays an important role in organ specific I/R injuries. This study investigated the efficacy of a small molecule C5a receptor (C5aR) antagonist against hepatic I/R injury. METHODS Total hepatic ischaemia or partial hepatic ischaemia were induced in rats, followed by a period of reperfusion. The C5aR antagonist, AcF-[OPdChaWR], was administered at 1 mg/kg i.v. or 10 mg/kg p.o. or s.c. before induction of ischaemia. Total hepatic I/R-induced mortality was measured and partial hepatic ischaemia injury was assessed by measuring the serum levels of liver enzymes, tissue or serum TNFalpha, liver and lung myeloperoxidase activity, the number of infiltrating neutrophils, neutrophilia and liver histopathology. RESULTS C5aR antagonist treatment reduced total hepatic I/R-induced mortality. In partial hepatic I/R rats, treatment with the C5aR antagonist significantly attenuated the increases in liver enzymes, serum and tissue TNFalpha, myeloperoxidase activity, infiltrating neutrophils, neutrophilia, and also reduced liver histopathology. CONCLUSIONS This study shows that an orally active, small molecule C5aR antagonist is effective in reducing the markers of tissue damage caused by I/R in the rat, suggesting an important role for C5a in I/R injuries in the liver.

[1]  A. Farhood,et al.  Effects of CXC chemokines on neutrophil activation and sequestration in hepatic vasculature. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[2]  J. Lemasters,et al.  Reperfusion injury after liver preservation for transplantation. , 1997, Annual review of pharmacology and toxicology.

[3]  J. Köhl,et al.  Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury. , 1999, Journal of immunology.

[4]  C. Smith,et al.  Complement and tumor necrosis factor‐α contribute to Mac‐1 (CD11b/CD18) up‐regulation and systemic neutrophil activation during endotoxemia in vivo , 1994, Journal of leukocyte biology.

[5]  John D Lambris,et al.  A Novel Role of Complement: Mice Deficient in the Fifth Component of Complement (C5) Exhibit Impaired Liver Regeneration1 , 2001, The Journal of Immunology.

[6]  D. Craik,et al.  Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. , 1999, Journal of medicinal chemistry.

[7]  W. Vogt,et al.  Chemotactic effects of the complement-derived peptides C3a, C3ai and C5a (classical anaphylatoxin) on rabbit and guinea-pig polymorphonuclear leukocytes , 1978, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  M. Heger,et al.  Impact of inhibition of complement by sCR1 on hepatic microcirculation after warm ischemia. , 2001, Microvascular research.

[9]  C. Håkansson,et al.  Multiple-system organ damage resulting from prolonged hepatic inflow interruption. , 1996, Archives of surgery.

[10]  D. Fairlie,et al.  Effects of a new C5a receptor antagonist on C5a‐ and endotoxin‐ induced neutropenia in the rat , 1999, British journal of pharmacology.

[11]  D. Remick,et al.  Inhibition of Kupffer cells reduced CXC chemokine production and liver injury. , 2001, The Journal of surgical research.

[12]  C. Smith,et al.  ACTIVATION OF KUPFFER CELLS AND NEUTROPHILS FOR REACTIVE OXYGEN FORMATION IS RESPONSIBLE FOR ENDOTOXIN-ENHANCED LIVER INJURY AFTER HEPATIC ISCHEMIA , 1995, Shock.

[13]  T. Ishiko,et al.  Kupffer cell production of cytokine‐induced neutrophil chemoattractant following ischemia/reperfusion injury in rats , 1996, Hepatology.

[14]  T. Noguchi,et al.  Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. , 2000, Blood.

[15]  C. Herfarth,et al.  Complement inhibition by soluble complement receptor type 1 improves microcirculation after rat liver transplantation. , 1998, Transplantation.

[16]  R. Strieter,et al.  Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. , 1990, The Journal of clinical investigation.

[17]  H. Jaeschke.  Pathophysiology of hepatic ischemia-reperfusion injury: the role of complement activation. , 1994, Gastroenterology.

[18]  John D Lambris,et al.  The Proinflammatory Mediators C3a and C5a Are Essential for Liver Regeneration , 2003, The Journal of experimental medicine.

[19]  J. D. Chambers,et al.  C5a- and tumor necrosis factor-alpha-induced leukocytosis occurs independently of beta 2 integrins and L-selectin: differential effects on neutrophil adhesion molecule expression in vivo. , 1995, Blood.

[20]  J. Henrion.  Ischemia/reperfusion injury of the liver: pathophysiologic hypotheses and potential relevance to human hypoxic hepatitis. , 2000, Acta gastro-enterologica Belgica.

[21]  K. McMasters,et al.  Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury , 2000, Hepatology.

[22]  Anna J. Strachan,et al.  Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat. , 2002, Arthritis and rheumatism.

[23]  M. Heger,et al.  In vivo microscopy reveals that complement inhibition by C1‐esterase inhibitor reduces ischemia/reperfusion injury in the liver , 2000, Transplant international : official journal of the European Society for Organ Transplantation.

[24]  Anna J. Strachan,et al.  Inhibition of immune‐complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist , 2001 .

[25]  K. Messmer,et al.  Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. , 1996, Shock.

[26]  H. Jaeschke,et al.  Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. , 1993, The American journal of physiology.

[27]  T. Williams,et al.  Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. , 1995, The Journal of clinical investigation.

[28]  D. Fairlie,et al.  A Potent Human C5a Receptor Antagonist Protects against Disease Pathology in a Rat Model of Inflammatory Bowel Disease 1 , 2003, The Journal of Immunology.

[29]  L. Klickstein,et al.  C5a‐stimulated human neutrophils use a subset of β2 integrins to support the adhesion‐dependent phase of superoxide production , 2000, Journal of leukocyte biology.

[30]  D. Fairlie,et al.  Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine. , 2002, The Journal of surgical research.

[31]  C. Smith,et al.  Mechanisms of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils. , 1996, Toxicology and applied pharmacology.

[32]  O. Götze,et al.  Anaphylatoxin C5a Actions in Rat Liver: Synergistic Enhancement by C5a of Lipopolysaccharide-Dependent α2-Macroglobulin Gene Expression in Hepatocytes Via IL-6 Release from Kupffer Cells1 , 2001, The Journal of Immunology.

[33]  Anna J. Strachan,et al.  A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. , 2003, Kidney international.

[34]  H. Jaeschke,et al.  Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats , 1992, Journal of leukocyte biology.

[35]  M. Lerner,et al.  Development of circulatory and metabolic shock following transient portal triad occlusion. , 1995, The Journal of surgical research.

[36]  M. Boermeester,et al.  Complement activation induced by ischemia-reperfusion in humans: a study in patients undergoing partial hepatectomy. , 1998, Journal of hepatology.

[37]  J. Engelhardt,et al.  Therapeutic approaches for ischemia/reperfusion injury in the liver , 1999, Journal of Molecular Medicine.

[38]  J. Engelhardt,et al.  CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. , 1997, The Journal of clinical investigation.

[39]  Anna J. Strachan,et al.  A New Small Molecule C5a Receptor Antagonist Inhibits the Reverse-Passive Arthus Reaction and Endotoxic Shock in Rats1 , 2000, The Journal of Immunology.

[40]  S. Rendig,et al.  Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. , 1995, The American journal of physiology.

[41]  E. Mackenzie,et al.  Expression of Receptors for Complement Anaphylatoxins C3a and C5a Following Permanent Focal Cerebral Ischemia in the Mouse , 2000, Experimental Neurology.

[42]  R. Mason,et al.  Role of Kupffer cells in the pathogenesis of hepatic reperfusion injury. , 1994, The American journal of physiology.

[43]  L. Toledo-Pereyra,et al.  Role of Kupffer cells in neutrophil activation and infiltration following total hepatic ischemia and reperfusion. , 1994, Circulatory shock.

[44]  D. Fairlie,et al.  Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats. , 2004, The Journal of surgical research.

[45]  C. Smith,et al.  Intercellular adhesion molecule 1 (ICAM‐1) expression and its role in neutrophil‐induced ischemia‐reperfusion injury in rat liver , 1995, Journal of leukocyte biology.

[46]  H. Jaeschke,et al.  Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. , 1991, Free radical research communications.